Galmed Pharmaceuticals Ltd. reports

Company location: Ramat Gan, Israel
Fiscal year end: 31 December

Galmed Pharmaceuticals Ltd. has filed 364 SEC EDGAR filings since 31 Dec 2013

Filter by type:
SC13G
20-F
6-K

SEC filing history

Showing 1-25 of 364 matching filings.

Per page

Current page

424B3 File 333-289703

424B3

Filing date: 22 Jun 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 22 Jun 2026
Reporting date: 22 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

POS EX File 333-289703

POS EX

Filing date: 08 Jun 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-289703

424B3

Filing date: 08 Jun 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 08 Jun 2026
Reporting date: 08 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 02 Jun 2026
Reporting date: 02 Jun 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 14 May 2026
Reporting date: 14 May 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 06 May 2026
Reporting date: 06 May 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 14 Apr 2026
Reporting date: 14 Apr 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 09 Apr 2026
Reporting date: 09 Apr 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-289703

EFFECT filing

Filing date: 01 Apr 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

POS AM File 333-289703

POS AM

Filing date: 31 Mar 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

20-F File 001-36345

20-F

Filing date: 31 Mar 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 18 Mar 2026
Reporting date: 18 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 05 Mar 2026
Reporting date: 05 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 04 Mar 2026
Reporting date: 04 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36345

6-K

Filing date: 09 Feb 2026
Reporting date: 09 Feb 2026
SEC evidence: Open document Open filing
Next action: Verify source filing